HOME >> MEDICINE >> NEWS
Innovative study finds way to 'bio-synthesize' an anti-cancer compound

In a project that could have far-reaching implications for natural-product drug development, scientists have shown how a microbe that lives inside sea squirts could be used to biosynthesize a chemical compound that may help fight cancer.

The photosynthetic microbe, Prochloron didemni, lives as an endosymbiont inside the sea squirt Lissoclinum patella. So far, scientists have not been able to culture the microbe anywhere else.

Ground-up extracts of that sea squirt have been shown to contain patellamides, small peptides that appear useful in treating some cancers. Until this study, scientists had suspected but had not proven that Prochloron microbes produce patellamides.

The research paper, published online this week in the Proceedings of the National Academy of Sciences (PNAS), demonstrates that Prochloron didemni produces two patellamide compounds (A and C) and pinpoints the gene pathways that are used in that chemical biosynthesis.

"Coral reefs and other ocean environments are like rainforests full of natural chemicals to potentially treat human disease," says Eric W. Schmidt, Ph.D., assistant professor of medicinal chemistry at the University of Utah's College of Pharmacy. "Unfortunately, it's difficult to supply pharmaceuticals from these delicate environments. We have solved this by finding specific genes for the synthesis of chemicals using laboratory bacteria."

Schmidt had isolated and prepared the DNA of the microbe samples collected from sea squirts in the seabed near the Republic of Palau in Micronesia. Jacques Ravel, Ph.D., and other scientists at The Institute for Genomic Research (TIGR) in Rockville, MD, then sequenced the Prochloron genome. Working with Schmidt, they found the chemical pathways in the microbe's gene sequence that are responsible for producing patellamide A and C.

Ravel, who led TIGR's role in the project, says: "For the first time, we have demonstrated the bacterial origin of a natural
'"/>

Contact: Phil Sahm
Phil.Sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences Center
9-May-2005


Page: 1 2 3

Related medicine news :

1. Innovative device to treat brain cancer shows promise in early studies
2. Innovative education scheme sees fewer rugby players suffering spinal injuries
3. Innovative movies show real-time immune-cell activity within tumors
4. GSA confers 2006 Richard Kalish Innovative Publication Award to Virginia Techs Calasanti
5. Innovative surgery corrects vision in kids with neurological disorders
6. Innovative approach affords Binghamton University researchers clearer view of autism
7. Innovative PhD program receives $850,000 grant from Howard Hughes Medical Institute
8. The Gerontological Society of America confers 2004 Richard Kalish Innovative Publication Award
9. Innovative Cancer Therapy for Tomorrow
10. Innovative drug Tarceva now available in Europe to tackle growing lung cancer epidemic
11. Innovative gel reduces post-operative pain

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Innovative study finds way bio synthesize anti cancer compound

(Date:5/24/2013)... 24, 2013 The Dictation Source recently ... of clients. As a result of its National marketing ... in 20 states around the nation. , Since 1991, ... services to the healthcare industry . Dictation Source is ... their years of clinical work experience to provide the ...
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... 101 Mobility® is a leading nationwide ... accessibility solutions for both consumer and commercial applications. ... ramps, vertical platform lifts, vehicle lifts for mobility ... elevators, among others. 101 Mobility operates over 30 ...
(Date:5/24/2013)... (HealthDay News) -- About one in five parents think ... up smoking, drinking or illicit drug use, a new ... experts at the Substance Abuse and Mental Health Services ... actually one of the most influential forces helping to ... "Surveys of teens repeatedly show that parents can make ...
(Date:5/24/2013)... 2013 The SunglassFIX Photo Contest ... all while learning how to make their sunglasses, ... Contestants only need to upload pictures of themselves, ... The Sunglass Fix on Facebook in order to ... largest lens replacement online store . ...
(Date:5/24/2013)... investigational device - the Helio System (TF-FA) - being ... Valve was successfully deployed in all four patients in ... high-risk aortic insufficiency reported at EuroPCR 2013. , The ... stabilise the SAPIEN XT valve for patients with aortic ... between the transcatheter heart valve and the dock. "This ...
Breaking Medicine News(10 mins):Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2
(Date:5/23/2013)... 23, 2013  Haemonetics Corporation (NYSE: HAE ) ... & EVP-Business Development, will present at The Deutsche Bank 38 ... Boston, MA on May 29, 2013 at 1:30pm ... The public may access Mr. Lindop,s presentation live ... Haemonetics Haemonetics (NYSE: HAE ) is ...
(Date:5/23/2013)... PAUL, Minn. , May 23, 2013  MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
Cached News: